review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Nives Pecina Slaus | Q67887610 |
P2093 | author name string | S Vukicevic | |
F Borovecki | |||
P2860 | cites work | Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma | Q21260421 |
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation | Q24292169 | ||
Genomic approaches to identifying transcriptional regulators of osteoblast differentiation | Q24796349 | ||
Regulation of bone mass in mice by the lipoxygenase gene Alox15 | Q28505413 | ||
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
NFAT and Osterix cooperatively regulate bone formation | Q31813054 | ||
EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin | Q34398493 | ||
Articular cartilage repair: the role of bone morphogenetic proteins | Q34694602 | ||
Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells | Q34868815 | ||
In vivo analysis of Wnt signaling in bone | Q36774960 | ||
Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. | Q38290706 | ||
Gene array analysis of osteoblast differentiation. | Q38303389 | ||
Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. | Q38312291 | ||
The role of angiogenesis in a murine tibial model of distraction osteogenesis. | Q38341820 | ||
Identification of estrogen-regulated genes of potential importance for the regulation of trabecular bone mineral density | Q38360055 | ||
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator | Q38363724 | ||
Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism | Q40345748 | ||
Gene therapy applications in orthopaedics | Q42431899 | ||
Gene expression changes accompanying p53 activity during estrogen treatment of osteoblasts | Q45019281 | ||
A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes | Q46555263 | ||
Expression of angiogenic factors during distraction osteogenesis | Q47316305 | ||
Expression profile of osteoblast lineage at defined stages of differentiation. | Q50771209 | ||
Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling. | Q52015949 | ||
Prediction of high risk Ewing's sarcoma by gene expression profiling. | Q54698704 | ||
Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays | Q60727809 | ||
Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
Eating bone or adding it: the Wnt pathway decides | Q79751142 | ||
Gene expression profiling in bone tissue of osteoporotic mice | Q80137031 | ||
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma | Q81489463 | ||
Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair | Q81560846 | ||
Orthopaedic applications of gene therapy | Q81757717 | ||
P433 | issue | 6 | |
P304 | page(s) | 799-805 | |
P577 | publication date | 2007-07-03 | |
P1433 | published in | International Orthopaedics | Q15767032 |
P1476 | title | Biological mechanisms of bone and cartilage remodelling--genomic perspective | |
P478 | volume | 31 |
Q35851209 | A novel recirculating flow-perfusion bioreactor for periosteal chondrogenesis |
Q37189012 | Abnormal expression of chondroitin sulphate N-acetylgalactosaminyltransferase 1 and Hapln-1 in cartilage with Kashin-Beck disease and primary osteoarthritis |
Q33969674 | Apolipoprotein E gene E2/E2 genotype is a genetic risk factor for vertebral fractures in humans: a large-scale study |
Q33969911 | Association of oestrogen receptor gene polymorphism with the long-term results of rotational acetabular osteotomy |
Q43074654 | Biological aspects of bone, cartilage and tendon regeneration |
Q53087759 | Bisphenol A Represses Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells through Downregulating the Expression of Insulin-like Growth Factor 1. |
Q38461065 | Bone Morphogenic Protein--mRNA upregulation after exposure to low frequency electric field |
Q38227444 | Bone marrow derived stem cells in joint and bone diseases: a concise review |
Q35184696 | Cartilage oligomeric matrix protein - inflammation biomarker in knee osteoarthritis |
Q38114791 | Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates |
Q36493059 | Chondrocyte BMP2 signaling plays an essential role in bone fracture healing. |
Q35082897 | Comparative characteristics of porous bioceramics for an osteogenic response in vitro and in vivo |
Q33970400 | Correlation between synovial fluid and serum IL-1beta levels after ACL surgery-preliminary report |
Q41893569 | Cysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model |
Q41979369 | Dual function of β-catenin in articular cartilage growth and degeneration at different stages of postnatal cartilage development |
Q41815073 | Effect of rat brain tissue extracts on osteoblast proliferation and differentiation |
Q51057041 | Evaluation of fibrin-based gene-activated matrices for BMP2/7 plasmid codelivery in a rat nonunion model. |
Q33969785 | Human cartilage glycoprotein 39--biomarker of joint damage in knee osteoarthritis |
Q39973587 | In vitro hypertrophy and calcification of human fracture haematoma-derived cells in chondrogenic differentiation |
Q83269669 | Low-intensity pulsed ultrasound accelerated callus formation, angiogenesis and callus remodeling in osteoporotic fracture healing |
Q39873206 | Methotrexate released in vitro from bone cement inhibits human stem cell proliferation in S/G2 phase. |
Q55417398 | Monthly Journal – International Orthopaedics. |
Q45866308 | Nonviral gene transfer to human meniscal cells. Part I: transfection analyses and cell transplantation to meniscus explants |
Q35652991 | Osteogenic differentiation is synergistically influenced by osteoinductive treatment and direct cell-cell contact between murine osteoblasts and mesenchymal stem cells |
Q33969649 | Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients' bone health |
Q33970719 | Periprosthetic strain magnitude-dependent upregulation of type I collagen synthesis in human osteoblasts through an ERK1/2 pathway |
Q37975963 | Post-genomics of bone metabolic dysfunctions and neoplasias. |
Q42568509 | Potential of exogenous cartilage proteoglycan as a new material for cartilage regeneration |
Q42646226 | Proteomic analysis of mineralising osteoblasts identifies novel genes related to bone matrix mineralisation |
Q33386046 | Regional and cellular localisation of BMPs and their inhibitors' expression in human fractures |
Q24617404 | Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study |
Q38172438 | The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing |
Q40028378 | The effect of platelet-rich plasma on osteochondral defects treated with mosaicplasty |
Q30495473 | The regenerative effect of platelet-rich plasma on healing in large osteochondral defects |
Q35197545 | Vascularised fibular graft for the treatment of congenital pseudarthrosis of the tibia: long-term complications in the donor leg. |